Novel Drug Delivery Systems Market Size - By Route of Administration (Oral Drug Delivery Systems, Injectable Drug Delivery Systems, Pulmonary Drug Delivery Systems, Transdermal Drug Delivery Systems, and Others), Mode of NDDS (Targeted Drug Delivery Systems, Controlled Drug Delivery Systems, Modulated Drug Delivery Systems) And By Region & Forecast, 2024-2033

<p>The Novel Drug Delivery Systems Market value was USD 18,234 Mn in 2023 and projected to reach USD 56,754 Mn by 2033 with a CAGR of 20.5% during 2023 to 2033.</p><table><tbody><tr><th scope='row'>Report Attribute</th><td>Description</td></tr><tr><th scope='row'>Market Size in 2023</th><td>USD 18,234 Million</td></tr><tr><th scope='row'>Market Forecast in 2033</th><td>USD 56,754 Million</td></tr><tr><th scope='row'>CAGR % 2024-2033</th><td>20.5%</td></tr><tr><th scope='row'>Base Year</th><td>2023</td></tr> <tr><th scope='row'>Historic Data</th><td>2016-2022</td></tr> <tr><th scope='row'>Forecast Period</th><td>2024-2033</td></tr><tr><th scope='row'>Report USP</th><td>Production, Consumption, company share, company heatmap, company production capacity, growth factors and more</td></tr><tr><th scope='row'>Segments Covered</th><td>by Route of Administration, Mode of NDDS</td></tr><tr><th scope='row'>Regional Scope</th><td>North America, Europe, APAC, South America and Middle East and Africa</td></tr> <tr><th scope='row'>Country Scope</th><td>U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria</td></tr><tr><th scope='row'>Key Companies</th><td>F. Hoffmann-La Roche AG, Merck & Co., Inc, Abbott Laboratories, Bayer AG, GlaxoSmithKline Plc, Sanofi SA., Novartis AG, Pfizer Inc.</td></tr></tbody></table>

<p>新型药物递送系统市场规模于2023年达到18,234百万美元，预计到2033年将达到56,754百万美元，在2023年至2033年间的复合年增长率预计为20.5%。</p><table><tbody><tr><th scope='row'>报告属性</th><td>描述</td></tr><tr><th scope='row'>2023年市场规模</th><td>18,234亿美元</td></tr><tr><th scope='row'>2033年市场规模预测</th><td>56,754亿美元</td></tr><tr><th scope='row'>2024-2033年CAGR %</th><td>20.5%</td></tr><tr><th scope='row'>基准年份</th><td>2023年</td></tr><tr><th scope='row'>历史数据</th><td>2016-2022年</td></tr><tr><th scope='row'>预测周期</th><td>2024-2033年</td></tr><tr><th scope='row'>报告独特卖点</th><td>生产、消费、公司市场份额、公司热力图、公司生产能力、增长因素等</td></tr><tr><th scope='row'>涵盖的细分市场</th><td>按给药途径、NDDS（新型药物递送系统）模式</td></tr><tr><th scope='row'>区域范围</th><td>北美、欧洲、亚太地区、南美洲、中东和非洲</td></tr><tr><th scope='row'>国家范围</th><td>美国；加拿大；英国；德国；法国；意大利；西班牙；比利时、荷兰、卢森堡；北欧国家；俄罗斯；中国；印度；日本；韩国；澳大利亚；印度尼西亚；泰国；墨西哥；巴西；阿根廷；沙特阿拉伯；阿联酋；埃及；南非；尼日利亚</td></tr><tr><th scope='row'>主要公司</th><td>F. Hoffmann-La Roche AG，默克公司（Merck & Co., Inc），雅培实验室（Abbott Laboratories），拜耳公司（Bayer AG），葛兰素史克公司（GlaxoSmithKline Plc），赛诺菲公司（Sanofi SA），诺华公司（Novartis AG），辉瑞公司（Pfizer Inc.）</td></tr></tbody></table>